ZO Multi-Therapy Hydroquinone System
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
- Titolare
- ZO Skin Health Inc.
- NPN o DIN-HM
- 80064165
- Stato
- Licenza non attiva
- Data della licenza
- 22 settembre 2015
- Data di revisione
- Non indicata
- Forma
- Crème
- Via di somministrazione
- Topique
- Tipo di domanda
- Non traditionnelle
L’analisi delle dosi orali non si applica senza una via esclusivamente orale accertata.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte |
|---|---|
| 1,4-Benzènediol | 4 % |
| Dioxyde de titane | 8 % |
Ingredienti non medicinali
Squalène, Phytosphingosine, EDTA de sodium, Aqua, Stéarate de PEG-100, Chlorure de stéapyrium, Stéarate de propylène glycol, Diméthicone, Extrait de branche/fruit/feuille de Nephelium Lappaceum, Poly(acrylamide), Ethylhexylglycérine, Cyclopentasiloxane, Dihydroxycétyle phosphate de sodium, Laureth-7, Néopentanoate d'isodécyle, Extrait de graine de Glycine Soja (Fève soja), Extrait de germes de Brassica oleracea italica (Brocoli), Squalane, Benzoate de sodium, Phényl triméthicone, Carbonate de sodium, Métabisulfite de sodium, Hydroxyde de sodium, Sébacate de di-isopropyle, Extrait de fleurs de Chamomille Recutita (Matricaria), Lauryl lactate, Phénoxyéthanol, Allantoïne, Isoparaffine en C13 à 14, Sulfate de sodium, Butylène glycol, Acide glycolique, Copolymères d'acrylates/de styrènes, Maltodextrine, Chlorphénésine, Sulfite de sodium, Chlorure de sodium, d-alpha tocophérol, Lauryl sulfate de sodium, Dihydrogénophosphate d'aminopropyl, Acide ascorbique, Palmitate d'éthylhexyle, Poly(glycéryl-3) poly(diméthylsiloxyéthyl) diméthicone, Jus de feuilles d'Aloe Barbadensis, bêta-D-glucane, Pentylène glycol, Silice, Caprylyl glycol, Glycérides de palme hydrogénés, Palmitate d'ascorbyle, Homarine HCl, Eau, Extrait de fleur/feuille/tige de Stachys officinalis, Triglycéride caprylique/caprique, Saponines, Alcool stéarylique, Huile de graine de Carthamus Tinctorius (Carthame), Acétate de dl-alpha tocophéryle, Acide stéarique, Propylène glycol, Cétéareth-20, Sorbate de potassium, bêta-glucane, Glycérine, Erythritol, Palmitate de rétinyle, Huile de graines d'Helianthus Annus (tournesol), Mélanine, Hydroxyde d'aluminium
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes | Non précisée | Non précisée | Non précisée |
Usi autorizzati in Canada
Melamin/Melamix: For the gradual lightening of hyperpigmented skin associated with various skin conditions such as chloasma, melasma, freckles, senile lentigines, and other skin discolourations. Skin bleaching/lightener. Glycogent: Helps to reduce the signs of chronic photodamage. Helps to correct skin discolouration. Provides antioxidants. Oclipse C Broad Spectrum Sunscreen SPF 50: Helps prevent sunburn. Broad Spectrum Sunscreen SPF 50: If used as directed with other sun protection measures, decreases the risk of skin cancer and early skin aging caused by the sun. Filters/screens UVA/UVB rays. Absorbs throughout the UVA/UVB spectrum to provide sunburn protection.
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Contra-Indications : Melamin/Melamix: Do not use this product if you are pregnant or breastfeeding or if you intend to become pregnant within three months of use. The safety of topical hydroquinone use during pregnancy has not been established. Melamin/Melamix: If irritation persists, contact a health care practitioner. Glycogent & Oclipse C Broad Spectrum Sunscreen SPF 50: Do not use on damaged or broken skin.
Testo originale in inglese.
Cautions and Warnings : All products: For external use only. All products: Keep out of reach of children. Oclipse C Broad Spectrum Sunscreen SPF 50: If swallowed, get medical help or contact a Poison Control Centre right away. Glycogent: Use only as directed. For sale through professionals only. Close treatment monitoring by a professional is required. Test product on a small area of skin before applying it to a large area. It is recommended that prior to exposure to the sun, users cover areas where AHAs have been applied with sunscreen. Contact of the product with the skin must be of limited frequency and duration. Avoid contact with eyes and mucous membranes such as nose and lips; Protect these sensitive areas with a moisturizer or petrolatum-based agent. If application causes severe discomfort or irritation, wash the area immediately with cold water. If irritation persists or worsens, consult a health care practitioner. Use with caution in patients who have a recent history of smoking, herpes simplex, dermatitis, psoriasis, or any other inflammatory condition in the skin area to be treated. Use with caution in patients who suffer from immunosuppression, or are taking oral contraceptives or tetracyclines. Use with caution in patients who have recently had medical or cosmetic treatment or procedure (e.g. laser therapy, surgical procedures, cosmetic filler, microdermabrasion, etc.). Do not use on inflamed, irritated, broken or infected skin. Do not use in patients who have taken isotretinoin in the past 12 months, have received recent chemotherapy or radiation therapy, or are taking photosensitizing medication. Do not use in patients with vitiligo, diabetes, active cold sores, or poor blood circulation, or who currently suffer from any type of infection. Oclipse C Broad Spectrum Sunscreen SPF 50: When using this product keep out of eyes. Rinse with water to remove. Melamin/Melamix: If you have a family history of, have or have had or are at risk of developing cancer, do not use. To be used only on the advice of a physician. In case of accidental ingestion, seek medical assistance or contact a Poison Control Centre immediately. Sun exposure should be avoided indefinitely by using a sunscreen agent, a sun block agent, or protective clothing to cover the bleached skin in order to prevent darkening from reoccurring and to protect skin from increase in skin due to AHAs. Use only as directed. A mild transient stinging or minor redness may occur in people with sensitive skin. Discontinue use and consult a doctor in case of irritation, rash, excessive inflammatory response or if a gradual blue-black darkening of the skin (exogenous ochronosis) occurs.
Testo originale in inglese.
Cautions and Warnings : Minor redness is acceptable, but where there is excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which case the product should be discontinued and the physician notified immediately. Do not use this product if you have used it or any of its ingredients before and skin sensitivity or irritation has occurred. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this product. Close patient supervision is recommended. A bitter taste and anesthetic effect may occur if applied to lips.
Testo originale in inglese.
Known Adverse Reactions : Melamin/Melamix: Hypersensitivity such as redness, burning, stinging, itching, peeling and dryness may occur; in such case, discontinue use and contact a health care practitioner. Glycogent: Hypersensitivity such as redness, burning sensation, dermatitis, swelling, blisters stinging, itching, peeling and dryness may occur; in such case, discontinue use and contact a health care practitioner. Oclipse C Broad Spectrum Sunscreen SPF 50: Stop and ask a doctor if rash occurs. Melamin/Melamix: Contains sodium metabisulfite, a sulfite that may cause serious allergic-type reactions including anaphylactic symptoms (e.g. hives, itching), and life threatening or less severe asthmatic episodes in certain susceptible persons.
Testo originale in inglese.
Fonte
Scheda ufficiale Health Canada, licenza 80064165
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
La data della prova di questo elenco di ingredienti è sconosciuta.
Il prodotto è cambiato? Fotografi la confezione.
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.